What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published
Group 2447.png

Dosing & Administration

Group 2453.png

Two Maintenance doses per year:

  • The initial dose will be followed by a single loading dose at 3 months

  •  A healthcare professional then administers 2 maintenance doses* of Leqvio per year.1

For additional administration & MOA. information watch the video below:

Leqvio Administration Video, Novartis Pro VIDEO

For additional Information about Leqvio, watch the video below:

Leqvio Support Video_1 VIDEO

Leqvio® API

PDF
View

References

  1. Leqvio 284 mg/1.5 ml Solution for injection prescribing information, Egyptian drug authority approval date: 2/4/2024

Approved by Egyptian Drug Authority: HF0424OA4729/092025. Invalidation date: 23/09/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg

Leqvio QR code

HF0424OA4729/092025
23/09/2027

 

        

Adverse Events Reporting

We encourage using the following Electronic reporting tool for reporting into the safety database directly:
If the electronic reporting tool is not working - please use the following: https://www.report.novartis.com
1 - Generic Mailbox: [email protected]
2 - CISCO: +20 2 2 2861000: Press 3 for Adverse Events Reporting